Related Experiment Video
Updated: Aug 20, 2026
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
[A pilot study of photon therapy for benign prostate hyperplasia (a report of 30 cases)]
Zengnan Mo1, Hengqian Huang, Dianxi Long
1Department of Urology, the First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530021.
Objective:
To investigate the clinical efficacy and safety of photon therapy for benign prostate hyperplasia (BPH).
Methods:
Thirty patients with severe BPH received brachytherapy of prostate photon treatment system irradiation for one month, with the active area of the applicator located in the rectum, and at a dosage of 726-810 cGy. International prostate symptom score (IPSS), quality of life (QOL), volume of prostate gland, maximum flow rate (Qmax), and residual urine were evaluated before and after the treatment.
Results:
After one-month treatment, 18 cases remarkably improved, 9 slightly improved and 3 had no response. There was significant improvement in IPSS, QOL, volume of prostate gland, Qmax and residual urine (P<0.01, except Qmax P = 0.038).
Conclusion:
Prostate photon treatment system can be used as a safe, effective, micro-invasive, convenient and economical therapy for severe BPH, especially applicable to older and weaker patients.
